These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 477318)
21. Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users. van der Spuy ZM; Sohnius U; Pienaar CA; Schall R Contraception; 1990 Dec; 42(6):597-609. PubMed ID: 2128047 [TBL] [Abstract][Full Text] [Related]
22. Hormonal consequences of "missing the pill". Wang E; Shi S; Cekan SZ; Landgren BM; Diczfalusy E Contraception; 1982 Dec; 26(6):545-66. PubMed ID: 6820336 [No Abstract] [Full Text] [Related]
23. The effect of contraceptive steroids on hypothalamic-pituitary function. Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765 [TBL] [Abstract][Full Text] [Related]
24. Pulsatile luteinizing hormone patterns in long term oral contraceptive users. Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046 [TBL] [Abstract][Full Text] [Related]
25. Modulation of ovarian function by an oral contraceptive containing 30 micrograms ethinyl estradiol in combination with 2.00 mg dienogest. Spona J; Feichtinger W; Kindermann C; Moore C; Mellinger U; Walter F; Gräser T Contraception; 1997 Sep; 56(3):185-91. PubMed ID: 9347211 [TBL] [Abstract][Full Text] [Related]
26. Some estrogenic effects of two oral contraceptives consisting of norgestrel and two different doses of ethynylestradiol. Miller JF; Fotherby K; Bye PG; Elstein M Contraception; 1979 Jul; 20(1):5-10. PubMed ID: 573191 [TBL] [Abstract][Full Text] [Related]
27. Clinical investigation of the biological effects of a new combination low-dose oral contraceptive ('Ovostat E'). Tarkkila T; Hulkko S; Alapiessa U; Kauraniemi T Curr Med Res Opin; 1977; 5(3):247-51. PubMed ID: 162661 [TBL] [Abstract][Full Text] [Related]
28. The lack of interaction between temafloxacin and combined oral contraceptive steroids. Back DJ; Tjia J; Martin C; Millar E; Mant T; Morrison P; Orme M Contraception; 1991 Apr; 43(4):317-23. PubMed ID: 1906791 [TBL] [Abstract][Full Text] [Related]
29. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. III. Effect of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis. Ling WY; Wrixon W; Acorn T; Wilson E; Collins J Fertil Steril; 1983 Nov; 40(5):631-6. PubMed ID: 6628707 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function. Scott JZ; Kletzky OA; Brenner PF; Mishell DR Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356 [TBL] [Abstract][Full Text] [Related]
31. The effects of ampicillin on oral contraceptive steroids in women. Back DJ; Breckenridge AM; MacIver M; Orme M; Rowe PH; Staiger C; Thomas E; Tjia J Br J Clin Pharmacol; 1982 Jul; 14(1):43-8. PubMed ID: 6809025 [TBL] [Abstract][Full Text] [Related]
32. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles. Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353 [TBL] [Abstract][Full Text] [Related]
33. Metabolic changes during treatment with two different progestogens. Refn H; Kjaer A; Lebech AM; Borggaard B; Schierup L; Bremmelgaard A Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):374-7. PubMed ID: 2115298 [TBL] [Abstract][Full Text] [Related]
34. The response of the pituitary-ovarian axis to pulsatile administration of gonadotropin-releasing hormone in long-term oral contraceptive users. Hemrika DJ; Slaats EH; Schoemaker J Am J Obstet Gynecol; 1994 Feb; 170(2):462-8. PubMed ID: 8116698 [TBL] [Abstract][Full Text] [Related]
35. Effects of combined oral contraceptive steroids on pituitary-ovarian function during the menstrual cycle of lactating women. Ryu K; Yu HK; Kwak HM; Hong SS Contraception; 1983 Mar; 27(3):299-310. PubMed ID: 6406140 [TBL] [Abstract][Full Text] [Related]
36. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol. Goebelsmann U; Mashchak CA; Mishell DR Am J Obstet Gynecol; 1985 Apr; 151(7):868-77. PubMed ID: 3920910 [TBL] [Abstract][Full Text] [Related]
37. Plasma profile on pituitary gonadotropins and ovarian steroids in women during 17 alpha-acetoxy- 11 beta-methyl-19-nor-progesterone administration. Pérez-Palacios G; Iramain C; Castañeda E; Rojo B; Long DW; Scaglia HE; Gual C Contraception; 1975 Jul; 12(1):37-43. PubMed ID: 1139948 [TBL] [Abstract][Full Text] [Related]
38. Effects of RU16117, an orally active weak oestrogenic compound, in postmenopausal women. Faure N; Labrie F; Olivier G; Tremblay M; Cloutier D; Lemay A; Ferland L; Azadian-Boulanger G; Bouton MM; Husson JM; Raynaud JP Maturitas; 1980 Jul; 2(2):155-68. PubMed ID: 6782429 [TBL] [Abstract][Full Text] [Related]
39. Influence of low dose oestrogen on circulating prolactin. LH and FSH levels in post-menopausal women. Robyn C; Vekemans M Acta Endocrinol (Copenh); 1976 Sep; 83(1):9-14. PubMed ID: 989226 [TBL] [Abstract][Full Text] [Related]
40. Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment. Elomaa K; Lähteenmäki P Contraception; 1999 Nov; 60(5):275-9. PubMed ID: 10717779 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]